Difference between revisions of "Small cell lymphomas"

Jump to navigation Jump to search
→‎Table of B-cell lymphoma: more info in table
m (note about MALT lymphoma)
(→‎Table of B-cell lymphoma: more info in table)
Line 25: Line 25:
| CD10+, BCL6+<ref name=Ref_Lester95>{{Ref Lester|95}}</ref>
| CD10+, BCL6+<ref name=Ref_Lester95>{{Ref Lester|95}}</ref>
| t(14,18)
| t(14,18)
| Clinical ?
| may transform into DLBCL
| Other ?
| cery common
|-
|-
| Mantle cell lymphoma
| Mantle cell lymphoma
Line 34: Line 34:
| t(11;14)(q13;q32)<ref>URL: [http://atlasgeneticsoncology.org/Anomalies/t1114ID2021.html http://atlasgeneticsoncology.org/Anomalies/t1114ID2021.html]. Accessed on: 10 August 2010.</ref>
| t(11;14)(q13;q32)<ref>URL: [http://atlasgeneticsoncology.org/Anomalies/t1114ID2021.html http://atlasgeneticsoncology.org/Anomalies/t1114ID2021.html]. Accessed on: 10 August 2010.</ref>
| Clinical ?
| Clinical ?
| Other ?
| DDx: [[Castleman disease]]
|-
|-
| Marginal zone lymphoma (MALT)
| Marginal zone lymphoma (includes MALT)
| Marginal zone
| Marginal zone
| Small
| Small
| CD21+, CD11c+, CD5-, CD23-<ref name=Ref_Lester95>{{Ref Lester|95}}</ref>
| CD21+, CD11c+, CD5-, CD23-<ref name=Ref_Lester95>{{Ref Lester|95}}</ref>
| Translocations
| Translocations
| Clinical
| classical GI lymphomas
| Other
| Other
|-
|-
Line 49: Line 49:
| CD10+, CD5-, TdT+, CD99+<ref name=Ref_Lester95>{{Ref Lester|95}}</ref>
| CD10+, CD5-, TdT+, CD99+<ref name=Ref_Lester95>{{Ref Lester|95}}</ref>
| Translocations ?
| Translocations ?
| Clinical ?
| aggressive (?)
| Other ?
| Other ?
|-
|-
Line 57: Line 57:
| CD5+, CD23+, CD43+, cyclin D1-
| CD5+, CD23+, CD43+, cyclin D1-
| Translocations ?
| Translocations ?
| Good prognosis
| good prognosis / indolent course
| Other ?
| Other ?
|- <!--
|- <!--
48,830

edits

Navigation menu